These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 15184638)

  • 21. Levetiracetam in the treatment of paroxysmal kinesiogenic choreoathetosis.
    Chatterjee A; Louis ED; Frucht S
    Mov Disord; 2002 May; 17(3):614-5. PubMed ID: 12112221
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Levetiracetam for tardive dystonia: a case report.
    Mangot A; Trivedi S; Kurrey R; Dubey V
    Neurol India; 2014; 62(5):559-60. PubMed ID: 25387636
    [No Abstract]   [Full Text] [Related]  

  • 23. Remember Keppra: seizure control with subcutaneous levetiracetam infusion.
    Murray-Brown FL; Stewart A
    BMJ Support Palliat Care; 2016 Mar; 6(1):12-3. PubMed ID: 26811092
    [No Abstract]   [Full Text] [Related]  

  • 24. Long-term continuation of levetiracetam in patients with refractory epilepsy.
    Krakow K; Walker M; Otoul C; Sander JW
    Neurology; 2001 Jun; 56(12):1772-4. PubMed ID: 11425954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppression of post-hypoxic and post-encephalitic myoclonus with levetiracetam.
    Genton P; Gelisse P
    Neurology; 2001 Sep; 57(6):1144-5. PubMed ID: 11571362
    [No Abstract]   [Full Text] [Related]  

  • 26. Levetiracetam as alternative treatment in Jeavons syndrome.
    Parissis D; Ioannidis P; Karacostas D
    J Neurol Sci; 2014 Jun; 341(1-2):147-9. PubMed ID: 24798222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Levetiracetam in progressive myoclonic epilepsy: an exploratory study in 9 patients.
    Crest C; Dupont S; Leguern E; Adam C; Baulac M
    Neurology; 2004 Feb; 62(4):640-3. PubMed ID: 14981187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predicting drug-resistant patients who respond to add-on therapy with levetiracetam.
    Kinirons P; McCarthy M; Doherty CP; Delanty N
    Seizure; 2006 Sep; 15(6):387-92. PubMed ID: 16766211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An open-label trial of levetiracetam for treatment of cervical dystonia.
    Tarsy D; Ryan RK; Ro SI
    Mov Disord; 2006 May; 21(5):734-5. PubMed ID: 16570301
    [No Abstract]   [Full Text] [Related]  

  • 30. Efficacy of levetiracetam in a patient with Unverricht-Lundborg progressive myoclonic epilepsy.
    Kinrions P; Ibrahim N; Murphy K; Lehesjoki AE; Järvela I; Delanty N
    Neurology; 2003 Apr; 60(8):1394-5. PubMed ID: 12707458
    [No Abstract]   [Full Text] [Related]  

  • 31. [Levetiracetam and restless leg syndrome].
    Lasaosa SS; Pellicer PL; Fernández LG
    Neurologia; 2008; 23(6):395-6. PubMed ID: 18597196
    [No Abstract]   [Full Text] [Related]  

  • 32. Levetiracetam for the treatment of essential tremor.
    Sullivan KL; Hauser RA; Zesiewicz TA
    Mov Disord; 2005 May; 20(5):640. PubMed ID: 15756652
    [No Abstract]   [Full Text] [Related]  

  • 33. [The results of the use of levetiracetam (keppra) in post-stroke epilepsy].
    Magomedova AKh; Magomedov MM; Magomedova AM; Magomaev MF
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(6 Pt 2):40-4. PubMed ID: 22983240
    [No Abstract]   [Full Text] [Related]  

  • 34. Levetiracetam in the treatment of vascular chorea: a case report.
    D'Amelio M; Callari G; Gammino M; Saia V; Lupo I; Salemi G; Ragonese P; Savettieri G
    Eur J Clin Pharmacol; 2005 Jan; 60(11):835-6. PubMed ID: 15580486
    [No Abstract]   [Full Text] [Related]  

  • 35. Levetiracetam in the treatment of infantile spasms.
    Lawlor KM; Devlin AM
    Eur J Paediatr Neurol; 2005; 9(1):19-22. PubMed ID: 15701562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of chorea with levetiracetam.
    Zesiewicz TA; Pathak A; Sullivan KL; Shamayev M; Hauser RA
    Eur J Clin Pharmacol; 2006 Jan; 62(1):87. PubMed ID: 16320048
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effectiveness of levetiracetam in the treatment of two cases of hypoxic encephalopathy with myoclonic status].
    de Gea-García JH; Villegas I; Sánchez Cámara S; Martínez Fresneda M
    Med Intensiva; 2011; 35(6):393-4. PubMed ID: 21296455
    [No Abstract]   [Full Text] [Related]  

  • 38. [Characteristics and indications of levetiracetam].
    Herranz JL; Argumosa A
    Rev Neurol; 2002 Sep; 35 Suppl 1():S110-6. PubMed ID: 12373663
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Levetiracetam (keppra) in epileptology].
    Kalinin VV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(3):74-7. PubMed ID: 18683359
    [No Abstract]   [Full Text] [Related]  

  • 40. [Non-convulsive epileptic status reverted with intravenous levetiracetam].
    Callén-Soto A; Pérez-Pérez S; Robles-Del Olmo B
    Rev Neurol; 2008 Nov 1-15; 47(9):501-2. PubMed ID: 18985603
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.